Support By : Li-lab
PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
---|---|---|---|---|---|
Prostate cancer | R-HSA-2990872 | map05215 | nimesulide | 4495 | drug-path |
Non-homologous end-joining | R-HSA-5693571 | map03450 | nimesulide | 4495 | drug-path |
Graft-versus-host disease | R-HSA-1643685 | map05332 | flumequine | 3374 | drug-path |
Hematopoietic cell lineage | R-HSA-173752 | map04640 | flumequine | 3374 | drug-path |
Autoimmune thyroid disease | R-HSA-1643685 | map05320 | flumequine | 3374 | drug-path |
Antigen processing and presentation | R-HSA-1236975 | map04612 | flumequine | 3374 | drug-path |
Adherens junction | R-HSA-451386 | map04520 | flumequine | 3374 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | flumequine | 3374 | drug-path |
Cell adhesion molecules (CAMs) | R-HSA-1031690 | 0 | flumequine | 3374 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | flumequine | 3374 | drug-path |
Asthma | R-HSA-444620 | map05310 | flumequine | 3374 | drug-path |
Allograft rejection | R-HSA-9679028 | map05330 | flumequine | 3374 | drug-path |
Vascular smooth muscle contraction | R-HSA-445355 | map04270 | flumequine | 3374 | drug-path |
Adipocytokine signaling pathway | R-HSA-168638 | map04920 | alverine | 15443 | drug-path |
B cell receptor signaling pathway | R-HSA-983705 | map04662 | alverine | 15443 | drug-path |
Huntington's disease | R-HSA-1643685 | 0 | alverine | 15443 | drug-path |
Long-term potentiation | R-HSA-9620244 | map04720 | alverine | 15443 | drug-path |
RNA polymerase | R-HSA-73864 | map03020 | alverine | 15443 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | methocarbamol | 222284 | drug-path |
Primary immunodeficiency | R-HSA-5601905 | map05340 | methocarbamol | 222284 | drug-path |